COVID-19 vaccination in children and university students

John P A Ioannidis1,2

  • 1Departments of Medicine, Epidemiology and Population Health, Biomedical Data Science, and Statistics, Stanford University, Stanford, CA, USA.

Insights

Optimizing COVID-19 vaccine strategies for youth is crucial. This commentary examines vaccine impacts on young people and society, considering varied global recommendations and mandates for university students.

Area of Science:

  • Public Health
  • Epidemiology
  • Vaccinology

Background:

  • COVID-19 vaccine strategies for children and young adults remain debated globally.
  • Vaccine recommendations and uptake vary significantly across countries, particularly for university students.
  • Mandates for student vaccination differ between the USA and European nations.

Purpose of the Study:

  • To analyze the multifaceted considerations for deploying COVID-19 vaccines in younger populations.
  • To evaluate the direct and indirect effects of youth vaccination on disease burden and societal function.
  • To address uncertainties regarding pandemic trajectory, endemicity, and immunity.

Main Methods:

  • The commentary synthesizes existing data and expert opinion on COVID-19 vaccine deployment in youth.
  • It involves estimating the impact of vaccination on reducing COVID-19 cases, fatalities, and adverse events.
  • Comparative analysis of vaccination policies and considerations across different global regions (USA, Europe, non-high-income countries).

Main Results:

  • Vaccination of youth may reduce disease burden in other age groups and improve societal functioning.
  • Estimates of direct benefits (reduced fatalities/illness) and risks (adverse events) from vaccines in youth are discussed.
  • Significant uncertainties persist regarding the pandemic's future course and the durability of immunity.

Conclusions:

  • Evidence-based recommendations for COVID-19 vaccination in young people require further understanding of risk factors and immunity.
  • Addressing residual uncertainties and regional differences is vital for effective vaccine deployment strategies.
  • Future research should focus on clinical/sociodemographic risk features and the longevity of natural versus vaccine-induced immunity.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
46.6K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
569
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
47
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
38
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
25
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
517